Cnbx Pharmaceuticals Inc (CNBX)

$0.00 0.00 (N/A)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 200,000
Avg Vol 22,384,025
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 100%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

CNBX Pharmaceuticals Inc., a clinical-stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome. The company is also developing various drug candidates, including PLP-33 for the local treatment of lateral spreading, or sessile, colorectal po...

Industry: Biotechnology
Sector: Healthcare
Phone: 877 424 2429
Address:
#3 Bethesda Metro Center, Suite 700, Bethesda, United States
shortlongman
shortlongman Apr. 24 at 8:29 PM
$FITY $CNBX $TIPS $CRDV $VISM Who successfully predicted a gap up stock
0 · Reply
Emergency123
Emergency123 Apr. 24 at 7:46 PM
$CNBX Next week it begins, glad to be in early!
0 · Reply
shortlongman
shortlongman Apr. 24 at 7:21 PM
$FITY Will this go really big like $CNBX or both
1 · Reply
Emergency123
Emergency123 Apr. 24 at 6:02 PM
$FLYYQ 🚀 $CNBX – Deep Value Biotech Flying Under the Radar 🚀 $CNBX is one of those ultra-low market cap biotech plays that could move FAST when attention comes in. 💊 Cancer-Focused Pipeline CNBX is developing multiple cannabinoid-based cancer therapies, including treatments targeting colorectal, breast, prostate, and melanoma cancers. Their lead candidates like Cannabics SR and RCC-33 are aimed at massive global markets. () Got eyes on it?
0 · Reply
Emergency123
Emergency123 Apr. 24 at 5:55 PM
$CRDV $CBDL $VISM 🚀 $CNBX – Deep Value Biotech Flying Under the Radar 🚀 $CNBX is one of those ultra-low market cap biotech plays that could move FAST when attention comes in. 💊 Cancer-Focused Pipeline CNBX is developing multiple cannabinoid-based cancer therapies, including treatments targeting colorectal, breast, prostate, and melanoma cancers. Their lead candidates like Cannabics SR and RCC-33 are aimed at massive global markets. ()
0 · Reply
Emergency123
Emergency123 Apr. 24 at 5:15 PM
$CNBX Whats up APE, hope you’re doing well. It’s been years. Took some time off. Glad to see you. In early! Lets Go One release and SKY bound
1 · Reply
DamnDirtyApe
DamnDirtyApe Apr. 24 at 5:03 PM
$CNBX my bid at 3 hasnt filled yet sinxe yesterday. I hope it does before they're gone.
0 · Reply
shortlongman
shortlongman Apr. 24 at 4:32 PM
$VISM $FITY Or $CNBX
1 · Reply
Emergency123
Emergency123 Apr. 24 at 4:24 PM
$CNBX
0 · Reply
Emergency123
Emergency123 Apr. 24 at 4:23 PM
$CNBX
0 · Reply
Latest News on CNBX
No data available.
shortlongman
shortlongman Apr. 24 at 8:29 PM
$FITY $CNBX $TIPS $CRDV $VISM Who successfully predicted a gap up stock
0 · Reply
Emergency123
Emergency123 Apr. 24 at 7:46 PM
$CNBX Next week it begins, glad to be in early!
0 · Reply
shortlongman
shortlongman Apr. 24 at 7:21 PM
$FITY Will this go really big like $CNBX or both
1 · Reply
Emergency123
Emergency123 Apr. 24 at 6:02 PM
$FLYYQ 🚀 $CNBX – Deep Value Biotech Flying Under the Radar 🚀 $CNBX is one of those ultra-low market cap biotech plays that could move FAST when attention comes in. 💊 Cancer-Focused Pipeline CNBX is developing multiple cannabinoid-based cancer therapies, including treatments targeting colorectal, breast, prostate, and melanoma cancers. Their lead candidates like Cannabics SR and RCC-33 are aimed at massive global markets. () Got eyes on it?
0 · Reply
Emergency123
Emergency123 Apr. 24 at 5:55 PM
$CRDV $CBDL $VISM 🚀 $CNBX – Deep Value Biotech Flying Under the Radar 🚀 $CNBX is one of those ultra-low market cap biotech plays that could move FAST when attention comes in. 💊 Cancer-Focused Pipeline CNBX is developing multiple cannabinoid-based cancer therapies, including treatments targeting colorectal, breast, prostate, and melanoma cancers. Their lead candidates like Cannabics SR and RCC-33 are aimed at massive global markets. ()
0 · Reply
Emergency123
Emergency123 Apr. 24 at 5:15 PM
$CNBX Whats up APE, hope you’re doing well. It’s been years. Took some time off. Glad to see you. In early! Lets Go One release and SKY bound
1 · Reply
DamnDirtyApe
DamnDirtyApe Apr. 24 at 5:03 PM
$CNBX my bid at 3 hasnt filled yet sinxe yesterday. I hope it does before they're gone.
0 · Reply
shortlongman
shortlongman Apr. 24 at 4:32 PM
$VISM $FITY Or $CNBX
1 · Reply
Emergency123
Emergency123 Apr. 24 at 4:24 PM
$CNBX
0 · Reply
Emergency123
Emergency123 Apr. 24 at 4:23 PM
$CNBX
0 · Reply
Emergency123
Emergency123 Apr. 24 at 4:23 PM
$CNBX
0 · Reply
shortlongman
shortlongman Apr. 24 at 3:17 PM
$FITY $CNBX OR $CRDV
0 · Reply
shortlongman
shortlongman Apr. 24 at 2:40 PM
$VISM $CRDV Or $CNBX
1 · Reply
shortlongman
shortlongman Apr. 24 at 2:23 PM
$CNBX Buy more or wait?
1 · Reply
Emergency123
Emergency123 Apr. 24 at 2:12 PM
$CNBX Loading 4’s now, thankful for my 3’s May not get that chance again! Be loading 5’s next week! TGIf
0 · Reply
Emergency123
Emergency123 Apr. 24 at 2:00 PM
$CNBX
0 · Reply
Emergency123
Emergency123 Apr. 24 at 12:12 PM
$CNBX $BURU $ELVG Barchart # 4 on the hot stocks on the move Things have changed for the good at $CNBX with new law change. Game ON, Get eyes here !
0 · Reply
Tiswazo
Tiswazo Apr. 24 at 9:58 AM
$CNBX let’s touch 6 today No tips on taxes NXGB same catalyst
1 · Reply
Emergency123
Emergency123 Apr. 23 at 10:03 PM
$CNBX Short Borrow Fee Rate: As of March 2026, the short borrow fee rate for CNBX was consistently 0.29. Market Position: The stock has experienced a high volume of price activity, with buy signals noted in February 2026, according to a report from StockInvest.us. Short Percentage: The short interest, while varying in total share count, represents a small, low-risk percentage of the float relative to its high, frequently increasing trading volume.
0 · Reply
Emergency123
Emergency123 Apr. 23 at 9:57 PM
$CNBX Based on data from early 2026, the short interest for CNBX Pharmaceuticals (CNBX) has shown fluctuations with a notable decrease in the number of shares shorted by late February 2026 compared to January.
0 · Reply
Emergency123
Emergency123 Apr. 23 at 9:37 PM
$CNBX
0 · Reply
Emergency123
Emergency123 Apr. 23 at 9:36 PM
$CNBX Share the knowledge with your peaople that have not found us yet. They will thank you later. $$$$ Bring the masses, DD legit, laws chsnging, perfect FN storm to turn this baby into a beast!
0 · Reply